GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Long-Term Debt

Haleon (XTER:H6D0) Long-Term Debt : €0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Long-Term Debt?

Haleon's Long-Term Debt for the quarter that ended in Mar. 2024 was €0 Mil.

Haleon's quarterly Long-Term Debt increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€10,111 Mil) but then declined from Dec. 2023 (€10,111 Mil) to Mar. 2024 (€0 Mil).

Haleon's annual Long-Term Debt increased from Dec. 2021 (€0 Mil) to Dec. 2022 (€11,367 Mil) but then declined from Dec. 2022 (€11,367 Mil) to Dec. 2023 (€10,111 Mil).


Haleon Long-Term Debt Historical Data

The historical data trend for Haleon's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Long-Term Debt Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
- - - 11,367.09 10,111.38

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10,095.90 - 10,111.38 -

Haleon  (XTER:H6D0) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Haleon Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Haleon's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon (XTER:H6D0) Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines